Combination treatment with artemisinin and oxaliplatin inhibits tumorigenesis in esophageal cancer EC109 cell through Wnt/β‐catenin signaling pathway

BACKGROUND: Esophageal cancer (EC) is a prevalent malignant cancer worldwide. Interestingly, the antimalaria compound artemisinin (ART) is also reported to have anticancer potential, although its underlying mechanism in EC is unclear. In this study, we explored the anticancer role of ART in EC109 an...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Tao, Wang, Jian, Ren, Wei, Liu, Zhu‐Long, Cheng, Yu‐Feng, Zhang, Xiao‐Mei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7396387/
https://www.ncbi.nlm.nih.gov/pubmed/32657048
http://dx.doi.org/10.1111/1759-7714.13570

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7396387/
https://www.ncbi.nlm.nih.gov/pubmed/32657048
http://dx.doi.org/10.1111/1759-7714.13570

Ejemplares similares